Delivery Order SPE2DB20D7059-SPE2DB25FGRE4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Paxlovid 300-100 mg dose packs in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of approximately $8,976.78 and is scheduled for completion by September 9, 2025. The contract utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,184.92 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Paxlovid 300/150-100mg tablets designated for severe cases. This is a firm fixed-price, competitively awarded delivery order with a completion date of September 2, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,348.63 to AmerisourceBergen Drug Corp on August 4, 2025, under a firm fixed-price contract with an ultimate completion date of August 5, 2025. This non-set-aside delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,014.68 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. The contract is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a non-competitive set-aside award. This delivery order operates as a child contract under AmerisourceBergen's larger indefinite delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,168.26 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,672.43 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office division. The contract will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. As a child order under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for pharmaceutical products and medical supplies. This competitively awarded, firm fixed-price delivery order has a ceiling value of $8,118.08 and an ultimate completion date of August 25, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 2, 2025. This firm fixed-price delivery order, valued at $1,028.55, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total ceiling of approximately $1 billion through December 2026. The contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $40,959.52 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,807.37 to AmerisourceBergen Drug Corp on September 2, 2025, with completion targeted for September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The delivery order will be fulfilled...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRE4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Paxlovid 300-100 mg dose packs in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $20,945.82 and is scheduled for completion by September 9, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. This prime indefinite delivery vehicle serves as a global pharmaceutical support contract enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. With no set-aside designation applied, this delivery order was competitively awarded and reflects AmerisourceBergen's established track record fulfilling federal medical supply requirements through open competition. The performance location is identified as Conshohocken, PA, where the company maintains its corporate operations and distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 9/8/25 |